Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The identification of a highly potent immunosuppressive/antiproliferative agent with
an acceptable toxicity profile has long been a goal for the management of severe plaque
psoriasis.